期刊文献+

口腔鳞状细胞癌S-100阳性树状细胞的免疫学意义 被引量:1

Immunobiological significance of S 100 protein positive dendritic cells (S 100 +DC) in patients with oral squamous cell carcinoma
原文传递
导出
摘要 为探讨S-100蛋白阳性树状细胞(S-100proteinpositivedendriticcels,S-100+DC)在口腔鳞癌的作用及其临床意义,我们采用卵白素-生物素复合物法染色技术,对60例口腔鳞癌组织S-100+DC进行了检测和半定量分析。结果显示,口腔鳞癌高分化组的S-100+DC密度较中、低分化组及对照组明显增高,经统计学分析,差异有显著性(P<0.05)。原发癌灶内的S-100+DC密度和局部淋巴结癌转移与否无相关性(P>0.05),但淋巴结内S-100+DC密度低者较易发生癌转移(P<0.05)。我们认为,S-100+DC分布可作为判定口腔鳞癌预后及病理组织学分级的参考指标。 The purpose of this study is to investigate the role and clinical significance of S 100 +DC in oral squamous cell carcinoma. Distribution of S 100 +DC in the tumor tissues and regional lymph nodes (LN) of 60 patients with oral squamous cell carcinoma was detected by immunohistochemistry (ABC). The results showed that the S 100 +DC density in tumor tissues was correlated with the tumor histologic grade ( P <0.05). The density of S 100 +DC was significantly higher in regional LN without tumor than those with metastases ( P <0.05). However, there was no difference of S 100 +DC in tumor tissues between patients with and without regional LN metastases. The distribution of S 100 +DC in tumor tissues and regional LN could be considered as a reference indicator of tumor histologic grade and clinical prognosis of patients.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 1997年第3期174-176,共3页 Chinese Journal of Stomatology
关键词 口腔肿瘤 鳞状细胞癌 树状细胞 免疫组织化学 S 100 protein Dendritic cell Oral squamous cell carcinoma Immunohistochemistry
  • 相关文献

同被引文献17

  • 1C. M. Rooney,M. A. Roskrow,N. Suzuki,C. Y. C. Ng,M. K. Brenner,H. Heslop.Treatment of relapsed Hodgkin’s disease using EBV-specific cytotoxic T cells[J].Annals of Oncology.1998(5)
  • 2Oreste Gallo,,Giacinto A,Lihonati MD, et al.Lanherhana cells related to prognosis in patients with laryngeal carcinoma[].Archives of Otolaryngology.1991
  • 3Schroeder S,Sehwarz W,Rehpenning W, et al.Langerhanscells and prognosis in patients with papillary thyroid carcinoma[].Cancer.1987
  • 4Khanna R,Burrows R,Moss DJ.Immune regulation in epstein-barr virus-Associated[].Diseases Microbiological Reviews.1995
  • 5Ranieri E,Herr W,Gambotto A,et al.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination[].Journal of Virology.1999
  • 6Su Z,Peluso M V,Raffegerst S H,et al.The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgin disease[].European Journal of Immunology.2001
  • 7Subklewe M,Chahroudi A,Schmaljohn A,et al.Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus[].Blood.1999
  • 8Yang S,Vervaert CE,Burch J J r,et al.Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity[].International Journal of Cancer.1999
  • 9Titzer S,Christensen O,Manzke O,et al.Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects[].British Journal of Haematology.2000
  • 10Vremec D,Shortman K.Dendritic cell subtypes in mouse lymphoid organs[].J Immunol.1997

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部